A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Clinical trial NCT06807268 · RECRUITING
Trial details
- NCT number
- NCT06807268
- Sponsor
- Pfizer
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-24
- Primary completion
- 2027-05-02
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.